Not all stem cells are good cells. Researchers have recently found a way to target harmful stem cells in patients suffering from breast cancer.
Using chemotherapy and a newly developed drug the team at Baylor College of Medicine is finding that relapses can be better prevented by targetting these cancer-causing stem cells instead of just the main tumors. Studies in mice and a small group of women have shown the promise of this technique.
Curing breast-cancer won’t happen all at once, but hopefully these breakthroughs mark another step forward in battling this enemy.